M Giovarelli - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Giovarelli

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999

A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.

The Journal of Experimental Medicine|August 4, 1998

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.

The EMBO Journal|July 6, 2000

Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic miceD Bellavia, A F Campese, E Alesse, et al.

Pageof 12

Search research articles

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999

A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.

The Journal of Experimental Medicine|August 4, 1998

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.

The EMBO Journal|July 6, 2000

Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic miceD Bellavia, A F Campese, E Alesse, et al.

Pageof 12